Universe Pharmaceuticals Schedules 2025 Shareholder Meeting
Ticker: UPC · Form: 6-K · Filed: Jul 29, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, proxy-statement
TL;DR
Uni Pharma (UPC) holding shareholder meeting July 29, 2025 - proxy statement filed.
AI Summary
Universe Pharmaceuticals INC is holding its 2025 Annual General Meeting of Shareholders on July 29, 2025. The company has furnished a Notice and Proxy Statement for this meeting, which is an important event for shareholders to participate in corporate governance.
Why It Matters
This filing indicates a key corporate governance event where shareholders can vote on company matters, potentially influencing future strategic decisions.
Risk Assessment
Risk Level: low — This is a routine corporate filing related to an annual shareholder meeting, not indicating any immediate financial or operational risks.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the 6-K report and subject of the annual meeting
- 2025 Annual General Meeting of Shareholders (event) — The subject of the furnished documents
- July 29, 2025 (date) — Date of the 2025 Annual General Meeting of Shareholders
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to furnish documents related to the 2025 Annual General Meeting of Shareholders of Universe Pharmaceuticals INC.
When is the 2025 Annual General Meeting of Shareholders scheduled to take place?
The 2025 Annual General Meeting of Shareholders is scheduled for July 29, 2025.
What specific document is being furnished with this filing?
A Notice and Proxy Statement for the 2025 Annual General Meeting of Shareholders, dated July 29, 2025, is being furnished.
Under which jurisdiction is Universe Pharmaceuticals INC incorporated?
Universe Pharmaceuticals INC is an exempted company incorporated under the laws of the Cayman Islands.
What is the principal executive office address of Universe Pharmaceuticals INC?
The principal executive office address is 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China, 343100.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 29, 2025 regarding Universe Pharmaceuticals INC (UPC).